NEU2022-008
NEUROMANCHA CENTER
Neuroscience area
Objectives and lines of research
– To confirm the usefulness of the kappa index in the diagnostic process of MS.
– To quantify the titer of antibodies against the spike (S) protein of SARSCOV2 after completing the vaccination regimen in patients with multiple sclerosis and various treatments versus healthy population.
– To determine the prevalence of cognitive impairment in patients diagnosed with multiple sclerosis in our health area.
– Identification of the demographic and clinical characteristics of patients with epilepsy in our health area.
– To quantify the titer of antibodies against the spike (S) protein of SARSCOV2 after completing the vaccination regimen in patients with multiple sclerosis and various treatments versus healthy population.
– To determine the prevalence of cognitive impairment in patients diagnosed with multiple sclerosis in our health area.
– Identification of the demographic and clinical characteristics of patients with epilepsy in our health area.
Research team
- MARTA PACHECO JIMÉNEZ
- ENRIQUE BOTIA PANIAGUA
- SANTIAGO NAVARRO MUÑOZ
- ÁNGELA DOMINGO SANTOS
- CRISTINA MANGAS AVELEIRA
- ANA GONZÁLEZ MANERO
- MARCOS CALVO ALZOLA
- IGNACIO RUEDA MEDINA
- MERCEDES GARCÍA JIMÉNEZ
- MERCEDES LÓPEZ RUIZ
IPs
MARTA PACHECO JIMÉNEZ
ENRIQUE BOTIA PANIAGUA
FINCA DE LA PERALEDA, S/N. 45071. Toledo
Developed by Nexora
